[Malignant pleural mesothelioma in patients hospitalised at the Clinical Hospital Centre Rijeka between 1989 and 2008].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Transliterated Title:
      Maligni mezoteliom pleure u bolesnika lijecenih u klinickome bolnickom centru Rijeka tijekom 1989-2008. Godine.
    • Source:
      Publisher: Institut za medicinska istraz̆ivanja i medicinu rada Country of Publication: Croatia NLM ID: 0373100 Publication Model: Print Cited Medium: Print ISSN: 0004-1254 (Print) Linking ISSN: 00041254 NLM ISO Abbreviation: Arh Hig Rada Toksikol Subsets: MEDLINE
    • Publication Information:
      Publication: <2016>- : Zagreb, Croatia : Institut za medicinska istraz̆ivanja i medicinu rada
      Original Publication: Zagreb, Croatia : Institute for Medical Research and Occupational Health
    • Subject Terms:
      Asbestos/*adverse effects ; Mesothelioma/*epidemiology ; Occupational Diseases/*epidemiology ; Pleural Neoplasms/*epidemiology; Croatia/epidemiology ; Environmental Exposure ; Female ; Humans ; Male ; Mesothelioma/etiology ; Occupational Diseases/etiology ; Pleural Neoplasms/etiology
    • Abstract:
      Malignant pleural mesothelioma (MPM) is a relatively rare tumour, mainly associated with occupational exposure to asbestos. We retrospectively analysed the records of MPM patients treated at the Pulmonology Department of the Clinic for Internal Diseases, Clinical Hospital Centre Rijeka between 1989 and 2008. to establish the incidence of MPM in that period. Between 1989 and 2008 the hospital received 121 MPM patients, 117 of whom were men and four women. We observed a continued increase in newly diagnosed MPM patients from year to year. Occupational exposure to asbestos was established in 72 patients who worked in shipbuilding. In our region the incidence of MPM has been rising significantly. We believe that this is not related to improved diagnostics, but to the long latency of the disease. This is why we expect this trend to continue for a while. In the U.S.A. and Europe, MPM incidence is expected to peak by 2020, while in countries with poor control over asbestos use this may take longer.
    • Accession Number:
      1332-21-4 (Asbestos)
    • Publication Date:
      Date Created: 20100922 Date Completed: 20101012 Latest Revision: 20161205
    • Publication Date:
      20231215
    • Accession Number:
      20853777